Profilo
Jennifer K.
Zimmons is currently the Investor Relations Contact at ProLung, Inc. She was previously the Head-Investor Relations at 9 Meters Biopharma, Inc.
Posizioni attive di Jennifer K. Zimmons
| Società | Posizione | Inizio |
|---|---|---|
| PROLUNG, INC. | Contatto Relazioni con gli Investitori | - |
Precedenti posizioni note di Jennifer K. Zimmons
| Società | Posizione | Fine |
|---|---|---|
| 9 METERS BIOPHARMA, INC. | Contatto Relazioni con gli Investitori | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| 9 METERS BIOPHARMA, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
ProLung, Inc.
 ProLung, Inc. Medical SpecialtiesHealth Technology ProLung, Inc. is a medical technology company, which specializes in predictive analytics technology, early stage lung cancer risk testing. It develops, tests and commercializes solutions which are designed to accelerate the time to diagnosis and expand the therapeutic window for lung cancer patients. Its product under the name of ProLung Test was developed to assess the risk of malignancy in lung nodules found in the chest by a Computed Tomography scan. The company was founded by Steven C. Eror on November 19, 2004 and is headquartered in Salt Lake City, UT. | Health Technology |
- Borsa valori
- Insiders
- Jennifer K. Zimmons
